Ncardia

Ncardia specializes in human induced pluripotent stem cell (iPSC) technology, providing high-quality cell models and screening assays to enhance drug discovery and development. The company enables therapeutic developers to make informed decisions early in the process, thereby increasing the likelihood of clinical success and reducing development timelines.

Traction 5/10

Leiden, Netherlands · HQ

Founded 20115810K+ followers

Biotechnology

Updated 7 months ago

Funding

Funding rounds are not available yet.

Founders

2 founders

Geoffrey Glass

CEO

Stefan Braam

Founder/CTO

Product

Features

Ncardia specializes in human induced pluripotent stem cell (iPSC) technology, providing high-quality cell models and screening assays to enhance drug discovery and development. The company enables therapeutic developers to make informed decisions early in the process, thereby increasing the likelihood of clinical success and reducing development timelines.